NSE ScannerOpen the scanner

Business Services · Miscellaneous Commercial Services · NSE: SYNGENE · data 2026-10-31

Syngene International Ltd.

₹402.7+1.03% on 30 OctHealth: Weak 2/10
Feb 2026Low ₹346 · High ₹482.5-10.0%

In plain words

Price: 40.7% below its 52-week high of ₹678.95.

Delivery: 45.7% of traded shares were kept for delivery over the last 10 sessions, against 52.9% over the last 60.

Latest results: a net profit of ₹32 cr for the quarter ended Sept 2026 (-52.0% on the same quarter a year earlier).

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹402.7
Market cap
₹16,252 cr
P/E
87.2
P/B
3.3
ROE
6.6%
ROCE
9.9%
Debt / equity
0.09
Dividend yield
0.31%
1-year return
-38.7%
52-week high
₹678.95
52-week low
₹344.45
Operating margin
13.0%

Growth

Revenue (last 12 months)₹3,522 cr
Net profit (last 12 months)₹186 cr
Sales growth, 3 years (yearly)5.5%
Profit growth, 3 years (yearly)-12.0%

At a glance

Ownership
Moderate

Promoters 52.6% (-0.1 pts in a year), pledged 0.0%, institutions 39.4%.

Valuation
High

P/E 87.2, P/B 3.3, dividend yield 0.3%. Price relative to earnings and book value (low is cheaper, not better).

Efficiency
Weak

ROE 6.6%, ROCE 9.9%, operating margin 13.0%: how much profit it earns on the money it uses.

Financials
Weak

Debt/equity 0.09, Profit growth -12.0% and sales growth 5.5% a year over 3 years.

Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.

Strengths and limitations

Strengths
  • Virtually debt-free (debt/equity 0.1 or less).
Limitations
  • Low return on equity (6.6%).
  • Profit fell 12.0% a year over 3 years.
  • Expensive on earnings (P/E 87.2).

Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.

Latest results in brief (Q2 FY27)

SYNGENE Q2 FY27 results (consolidated figures, as filed on NSE).

Revenue was ₹832.7 crore, down 8.6% YoY and up 13.1% QoQ.

Net profit was ₹32.2 crore, down 52% YoY and a turn to profit from a loss last quarter.

Operating margin was 17.7% (21.9% a year ago).

EPS was ₹0.8, down 52.1% YoY and positive against a negative EPS last quarter.

SYNGENE के Q2 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।

राजस्व: ₹832.7 करोड़; पिछले साल की तुलना में 8.6% की गिरावट, पिछली तिमाही की तुलना में 13.1% की बढ़त।

शुद्ध मुनाफ़ा: ₹32.2 करोड़; पिछले साल की तुलना में 52% की गिरावट, पिछली तिमाही के घाटे से मुनाफ़े में आया।

ऑपरेटिंग मार्जिन: 17.7% (एक साल पहले 21.9%)।

EPS: ₹0.8; पिछले साल की तुलना में 52.1% की गिरावट, पिछली तिमाही के ऋणात्मक EPS से धनात्मक हुआ।

SYNGENEના Q2 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).

આવક (રેવન્યુ): ₹832.7 કરોડ; ગયા વર્ષની સરખામણીએ 8.6% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 13.1% વધારો.

ચોખ્ખો નફો: ₹32.2 કરોડ; ગયા વર્ષની સરખામણીએ 52% ઘટાડો, ગયા ક્વાર્ટરની ખોટમાંથી નફામાં આવી.

ઓપરેટિંગ માર્જિન: 17.7% (એક વર્ષ પહેલાં 21.9%).

EPS: ₹0.8; ગયા વર્ષની સરખામણીએ 52.1% ઘટાડો, ગયા ક્વાર્ટરના નકારાત્મક EPSથી હકારાત્મક થઈ.

Written from the filed numbers. Not a recommendation.

Smart-money activity

27/100 · Neutral over the last ~60 sessions, data 2026-10-30

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Story so far

2026-10-27: Q2 FY27 results: profit −52.0% YoY2026-07-29: Q1 FY27 results: turned to loss vs a year ago2026-06-25: Dividend ₹1.25 (ex-date)2026-04-29: Q4 FY26 results: profit −19.3% YoY

● Results   ● Dividend

From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.

Quarterly results (consolidated)

QuarterRevenueNet profitProfit YoYOp. marginEPS ₹
Sept 2026₹833 cr₹32 cr-52.0%17.7%0.8
Jun 2026₹736 cr₹-9 cr-110.4%12.3%-0.22
Mar 2026₹1,037 cr₹148 cr-19.3%29.3%3.68
Dec 2025₹917 cr₹15 cr-88.6%22.8%0.37

Shareholding trend

HolderSept 2026Jun 2026Mar 2026Dec 2025
Promoters52.59%52.59%52.68%52.68%
Foreign institutions (FII)10.14%11.82%13.90%14.96%
Domestic institutions (DII)29.30%28.02%26.44%25.84%
Mutual funds27.10%25.78%24.18%22.71%
Retail investors4.95%4.77%4.21%3.93%
Number of shareholders1,34,0081,42,2771,35,6051,31,750

Common questions

What was Syngene International Ltd.'s latest quarterly profit?

Syngene International Ltd. reported a net profit of ₹32 cr for the quarter ended Sept 2026 (-52.0% on the same quarter a year earlier), on revenue of ₹833 cr.

How much do promoters hold in Syngene International Ltd.?

Promoters held 52.59% of Syngene International Ltd. at the end of Sept 2026, with 0.00% of promoter shares pledged.

Is Syngene International Ltd. debt-free?

Its latest reported debt-to-equity ratio is 0.09, which is very low.

What is Syngene International Ltd.'s P/E ratio?

About 87.2, based on the last 12 months' earnings and a price of ₹402.7 (data 2026-10-31).

What is the 52-week high and low of Syngene International Ltd.?

The 52-week high is ₹678.95 and the 52-week low is ₹344.45.

Mutual funds holding Syngene International Ltd.

From the monthly portfolios of the fund houses the site reads, as of 2026-09-30. 11 schemes holding about ₹1,332 cr; funds that hold it outside their top holdings may not be listed.

SchemeFund house% of fundValue
NIPPON INDIA SMALL CAP FUNDNippon India Mutual Fund0.60%₹485 cr
SBI Multi Asset Allocation FundSBI Mutual Fund1.22%₹257 cr
Nippon India Focused FundNippon India Mutual Fund2.71%₹219 cr
NIPPON INDIA PHARMA FUNDNippon India Mutual Fund1.40%₹128 cr
Mirae Asset Focused FundMirae Asset Mutual Fund1.85%₹118 cr
SBI Healthcare Opportunities FundSBI Mutual Fund1.12%₹66 cr
Nippon India Innovation FundNippon India Mutual Fund1.64%₹48 cr
ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUNDAditya Birla Sun Life Mutual Fund0.64%₹7 cr
ADITYA BIRLA SUN LIFE NIFTY SMALLCAP 50 INDEX FUNDAditya Birla Sun Life Mutual Fund0.82%₹3 cr
Nippon India MNC FundNippon India Mutual Fund0.46%₹2 cr
Mirae Asset Nifty 500 Healthcare ETFMirae Asset Mutual Fund0.51%₹0 cr

Compared with similar companies

CompanyPriceMarket capP/EP/BROEROCEDebt/eq.1-yr return
Syngene International Ltd.₹402.7₹16,252 cr87.23.36.6%9.9%0.09-38.7%
Sagility Limited₹42.08₹19,662 cr19.21.910.3%12.4%0.11-21.3%
International Gemological Institute Ltd₹397.75₹17,181 cr26.79.844.6%51.8%0.1+17.3%
Choice International Limited₹721.35₹16,072 cr65.9—16.1%—0.54-12.2%
eClerx Services Limited₹1,556.7₹14,641 cr20.34.929%31.2%0.15-32.8%
Concord Biotech Ltd.₹1,245.6₹13,028 cr46.16.313.6%15.1%0-14.4%

Compare SYNGENE with SAGILITY in detail →

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SYNGENE in NSE Scanner →
Share on WhatsAppShare on Telegram